|
TOMM70A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.33066907387547E-16 |
| Normal-vs-Stage2 |
9.828900E-04 |
| Normal-vs-Stage3 |
2.796400E-03 |
| Normal-vs-Stage4 |
2.687600E-02 |
| Stage1-vs-Stage2 |
3.799800E-01 |
| Stage1-vs-Stage3 |
7.602600E-01 |
| Stage1-vs-Stage4 |
3.541100E-03 |
| Stage2-vs-Stage3 |
4.336400E-01 |
| Stage2-vs-Stage4 |
2.334300E-02 |
| Stage3-vs-Stage4 |
1.088030E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62436730732907E-12 |
| Normal-vs-AfricanAmerican |
1.54659999995754E-06 |
| Normal-vs-Asian |
1.358180E-01 |
| Caucasian-vs-AfricanAmerican |
9.011200E-01 |
| Caucasian-vs-Asian |
9.516200E-01 |
| AfricanAmerican-vs-Asian |
9.298400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
5.00440000550384E-09 |
| Male-vs-Female |
2.254600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.79310000000466E-05 |
| Normal-vs-Extreme_Weight |
6.25789975394753E-10 |
| Normal-vs-Obese |
5.16110000292613E-08 |
| Normal-vs-Extreme_Obese |
3.691600E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.917800E-01 |
| Normal_Weight-vs-Obese |
1.439590E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.485200E-01 |
| Extreme_Weight-vs-Obese |
6.006800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.177000E-01 |
| Obese-vs-Extreme_Obese |
2.655600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.299000E-03 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
3.05055980476254E-12 |
| Normal-vs-Age(81-100Yrs) |
1.587590E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.712800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.428600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.156000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.501400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.420000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.713400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
<1E-12 |
| Normal-VS-Type2 PRCC |
2.93380000004895E-06 |
| Normal-VS-KIRP CIMP |
6.254800E-01 |
| Normal-VS-Unclassified PRCC |
8.00390000000872E-05 |
| Type1 PRCC-VS-Type2 PRCC |
1.455830E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.99873451123267E-12 |
| Type1 PRCC-VS-Unclassified PRCC |
6.203400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.26229999999994E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
8.960100E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.38039999999451E-05 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.54772999999553E-05 |
| Normal-vs-N1 |
5.675400E-03 |
| Normal-vs-N2 |
8.018400E-01 |
| N0-vs-N1 |
6.639000E-01 |
| N0-vs-N2 |
1.184250E-03 |
| N1-vs-N2 |
1.164450E-02 |
|
|
